跳至主要内容
临床试验/CTRI/2023/11/060343
CTRI/2023/11/060343招募中4 期

An open-label, single-centric, Interventional clinical study to assess theeffectiveness of P Grace in the Management of Benign Prostatic Hyperplasia (BPH). - NI

utra Grace0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Aged 45 years and above male subjects.
  • Subjects must have low to moderate BPH symptoms.
  • Subjects having symptoms such as delay in initiating micturition,
  • hesitancy, weak urinary stream, straining to void, sensation of
  • incomplete emptying and terminal dribbling.
  • Subjects with increased residual urine volume.
  • USG prostate volume not more than 80 cc.
  • Nocturia, Urgency, bladder pain, dysuria.
  • Willingness to sign the informed consent, follow the protocol, and
  • participate in clinical trials voluntarily.

排除标准

  • Patients with malignancy, Congenital deformities of urogenital tract or
  • any pathology other than BPH.
  • Patients with high Diabetes Mellitus Hypertension
  • systolic 140 mm Hg or higher diastolic 90 mm Hg or higher, Renal
  • disorders or any other systemic disease.
  • Patients planned for surgical treatment of BPH.
  • Urinary bladder calculus.
  • History of chronic prostatic diseases.
  • Patients with disturbed low BPH associated QoL scores.
  • Allergy or sensitivity to pumpkin seed oil.

研究者

发起方
utra Grace

相似试验